Report Company Directory
- US HG Research: Pfizer (PFE): 3Q24 Earnings - Not The Beat We Were Looking for, But Progress Nevertheless by Barclays
- US Investment Grade: Top Swaps in Yankees: Election Edition by Barclays
- UPDATE: US HG Research: Pfizer (PFE): Starboard Wars: Pfizer Strikes Back by Barclays
- US HG Research: Healthcare, Pharma, Health Insurance: What's the Issue? Supply Forecast Looks Limited by Barclays
- US HG Research: Pharmaceuticals: Reevaluating Relative Value Following Earnings and IRA Impact by Barclays
- US Investment Grade: Top swaps in Yankees: French elections create opportunities by Barclays
- US Investment Grade: Top Swaps in Yankees: Cons. Non-Cyc, Utilities, Cap Goods, Comms, Tech, Banks by Barclays
- US Investment Grade: Top Swaps in Yankees: Banks, Utilities, Comms, and Energy by Barclays
- US HG Research: Pharmaceuticals: 4Q23 Post-Earnings & Issuance Recap — Deleveraging Stories, Execution Risk by Barclays
- US HG Research: Bristol-Myers (BMY): Initiate On Bristol-Myers With Overweight — Finding Value Peering Over the Cliff by Barclays